Leflunomide plus low-dose prednisone in patients with progressive IgA nephropathy: a multicenter, prospective, randomized, open-labeled, and controlled trial
NefrologiaSobre o estudo
- Desenho
- Ensaio clínico randomizado
- Nível de evidência
- 2 · Nova evidência
- Revista
- Renal failure
- Publicado em
- 1 dez 2021
- Citações
- 0
O resumo deste estudo é do publisher e não tem licença aberta: por isso mostramos aqui só os dados do estudo, e o texto fica na fonte original, nos links abaixo.
O estudo original
Leflunomide plus low-dose prednisone in patients with progressive IgA nephropathy: a multicenter, prospective, randomized, open-labeled, and controlled trial
Zhaohui Ni, Zhen Zhang, Zanzhe Yu, Fuming Lu, Changlin Mei, Xiaoqiang Ding, Weijie Yuan, Wei Zhang, Gengru Jiang, Min Sun et al.
Descritores MeSH
- Leflunomide
- Glomerulonephritis, IGA
- Immunosuppressive Agents
- Prednisone
- Proteinuria
- Female
- Glomerular Filtration Rate
- Prospective Studies
- Humans
- Young Adult
Veja também
Estudos relacionados
- A post hoc analysis of BLISS-LN found Belimumab plus mycophenolate mofetil improves kidney outcomes versus placebo plus mycophenolate mofetil in active lupus nephritis
- Efficacy and Safety of Obinutuzumab in Active Lupus Nephritis
- Efficacy and safety of TRF-budesonide in IgA nephropathy treatment: a meta-analysis
- Potential benefits and related treatment effects of calcineurin inhibitors combined with steroid for IgA nephropathy: a systematic review and meta-analysis